-
Je něco špatně v tomto záznamu ?
Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis
Z. Hladinova, Z. Hruskova, B. Svobodova, K. Malickova, V. Lanska, P. Konopásek, E. Jancova, R. Rysava, CL. Edelstein, V. Tesar,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1992
Free Medical Journals
od 1992
Hindawi Publishing Open Access
od 1992-01-01
PubMed Central
od 1992
Europe PubMed Central
od 1992
ProQuest Central
od 2014-01-01
Open Access Digital Library
od 1992-01-01
Open Access Digital Library
od 1992-01-01
Open Access Digital Library
od 1992-01-01
Medline Complete (EBSCOhost)
od 1997-02-01
Health & Medicine (ProQuest)
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1992
PubMed
25802482
DOI
10.1155/2015/603750
Knihovny.cz E-zdroje
- MeSH
- ANCA-asociované vaskulitidy imunologie MeSH
- dospělí MeSH
- interleukin 33 krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- receptory buněčného povrchu krev MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: ST2, a member of the interleukin-1 receptor family, is selectively expressed on Th2 cells and mediates important Th2 functions. IL-33 is a specific ligand of ST2. The aim of the study was to determine whether serum levels of soluble ST2 (sST2) or IL-33 predict activity of the disease in patients with ANCA-associated vasculitides (AAV). METHODS: 139 AAV patients and 62 controls were studied. IL-33 and sST2 in the blood were measured with a commercially available ELISA. RESULTS: Newly diagnosed AAV patients had higher sST2 levels than controls (P < 0.01). Levels of sST2 were significantly higher in active newly diagnosed AAV patients than in patients with remission (P < 0.001). IL-33 levels were higher in AAV patients than in the control groups (P = 0.002). However, serum IL-33 levels were not increased in patients with active AAV compared to patients in remission. IL-33 levels were higher in patients with granulomatosis with polyangiitis than in patients with microscopic polyangiitis (P = 0.012). CONCLUSIONS: Serum sST2, but not serum IL-33, may be a marker of activity in AAV patients.
Division of Renal Diseases and Hypertension University of Colorado Denver Aurora CO 800 45 USA
Statistical Unit Institute for Clinical and Experimental Medicine 140 21 Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020926
- 003
- CZ-PrNML
- 005
- 20160727122040.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2015/603750 $2 doi
- 024 7_
- $a 10.1155/2015/603750 $2 doi
- 035 __
- $a (PubMed)25802482
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hladinova, Z $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 245 10
- $a Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis / $c Z. Hladinova, Z. Hruskova, B. Svobodova, K. Malickova, V. Lanska, P. Konopásek, E. Jancova, R. Rysava, CL. Edelstein, V. Tesar,
- 520 9_
- $a OBJECTIVE: ST2, a member of the interleukin-1 receptor family, is selectively expressed on Th2 cells and mediates important Th2 functions. IL-33 is a specific ligand of ST2. The aim of the study was to determine whether serum levels of soluble ST2 (sST2) or IL-33 predict activity of the disease in patients with ANCA-associated vasculitides (AAV). METHODS: 139 AAV patients and 62 controls were studied. IL-33 and sST2 in the blood were measured with a commercially available ELISA. RESULTS: Newly diagnosed AAV patients had higher sST2 levels than controls (P < 0.01). Levels of sST2 were significantly higher in active newly diagnosed AAV patients than in patients with remission (P < 0.001). IL-33 levels were higher in AAV patients than in the control groups (P = 0.002). However, serum IL-33 levels were not increased in patients with active AAV compared to patients in remission. IL-33 levels were higher in patients with granulomatosis with polyangiitis than in patients with microscopic polyangiitis (P = 0.012). CONCLUSIONS: Serum sST2, but not serum IL-33, may be a marker of activity in AAV patients.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ANCA-asociované vaskulitidy $x imunologie $7 D056648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin 33 $x krev $7 D000067596
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a receptory buněčného povrchu $x krev $7 D011956
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hruskova, Z $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic ; Institute of Immunology and Microbiology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Svobodova, B $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Malickova, K $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Lanska, V $u Statistical Unit, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
- 700 1_
- $a Konopásek, P $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Jancova, E $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Rysava, R $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 700 1_
- $a Edelstein, C L $u Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO 800 45, USA.
- 700 1_
- $a Tesar, V $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
- 773 0_
- $w MED00006378 $t Mediators of inflammation $x 1466-1861 $g Roč. 2015, č. - (2015), s. 603750
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25802482 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160727122301 $b ABA008
- 999 __
- $a ok $b bmc $g 1155596 $s 945454
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 2015 $c - $d 603750 $e 20150223 $i 1466-1861 $m Mediators of inflammation $n Mediators Inflamm $x MED00006378
- LZP __
- $a Pubmed-20160722